Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy in Elderly Patients with Non-M3 Acute Myelogenous Leukemia in First Complete Remission-Reference-Cited by-同舟云学术

Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy in Elderly Patients with Non-M3 Acute Myelogenous Leukemia in First Complete Remission

Published:2011-03 Issue:3 Volume:17 Page:401-411
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kurosawa Saiko,Yamaguchi Takuhiro,Uchida Naoyuki,Miyawaki Shuichi,Usuki Kensuke,Watanabe Masato,Yamashita Takuya,Kanamori Heiwa,Tomiyama Junji,Nawa Yuichiro,Yano Shingo,Takeuchi Jin,Yakushiji Kazuaki,Sano Fumiaki,Uoshima Nobuhiko,Yano Takahiro,Nannya Yasuhito,Moriuchi Yukiyoshi,Miura Ikuo,Takaue Yoichi,Fukuda Takahiro

Funder

Japanese Ministry of Health, Labour and Welfare and the Advanced Clinical Research Organization

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?;Appelbaum;Best Pract Res Clin Haematol,2008

2. Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B;Frohling;Blood,2006

3. Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial;Gardin;Blood,2007

4. Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial;van der Holt;Br J Haematol,2007

5. Age and acute myeloid leukemia;Appelbaum;Blood,2006

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-08-30

2. Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study;Clinical Cancer Research;2024-03-22

3. Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG);Journal of Geriatric Oncology;2023-09

4. The measurement and use of patient-reported outcomes in the setting of hematopoietic stem cell transplantation;Japanese Journal of Transplantation and Cellular Therapy;2023

5. Allogeneic hematopoietic cell transplantation for older patients;Hematology;2021-12-10